China · Delayed Price · Currency is CNY BMC Medical Statistics
Total Valuation
BMC Medical has a market cap or net worth of CNY 4.97 billion. The enterprise value is 2.63 billion.
| Market Cap | 4.97B |
| Enterprise Value | 2.63B |
Important Dates
The last earnings date was Wednesday, October 28, 2026.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | May 28, 2026 |
Share Statistics
BMC Medical has 123.39 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Current Share Class | 123.39M |
| Shares Outstanding | 123.39M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | +0.61% |
| Owned by Insiders (%) | 30.51% |
| Owned by Institutions (%) | 20.09% |
| Float | 55.24M |
Valuation Ratios
The trailing PE ratio is 21.60 and the forward PE ratio is 17.39.
| PE Ratio | 21.60 |
| Forward PE | 17.39 |
| PS Ratio | 3.45 |
| PB Ratio | 1.59 |
| P/TBV Ratio | 1.61 |
| P/FCF Ratio | 62.02 |
| P/OCF Ratio | 42.82 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.44, with an EV/FCF ratio of 32.87.
| EV / Earnings | 11.37 |
| EV / Sales | 1.83 |
| EV / EBITDA | 8.44 |
| EV / EBIT | 9.04 |
| EV / FCF | 32.87 |
Financial Position
The company has a current ratio of 4.74, with a Debt / Equity ratio of 0.18.
| Current Ratio | 4.74 |
| Quick Ratio | 4.27 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 1.78 |
| Debt / FCF | 6.92 |
| Interest Coverage | 126.02 |
Financial Efficiency
Return on equity (ROE) is 7.78% and return on invested capital (ROIC) is 35.19%.
| Return on Equity (ROE) | 7.78% |
| Return on Assets (ROA) | 4.92% |
| Return on Invested Capital (ROIC) | 35.19% |
| Return on Capital Employed (ROCE) | 9.27% |
| Weighted Average Cost of Capital (WACC) | 6.25% |
| Revenue Per Employee | 1.56M |
| Profits Per Employee | 250,977 |
| Employee Count | 923 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 3.97 |
Taxes
In the past 12 months, BMC Medical has paid 38.59 million in taxes.
| Income Tax | 38.59M |
| Effective Tax Rate | 13.93% |
Stock Price Statistics
The stock price has decreased by -33.43% in the last 52 weeks. The beta is 0.48, so BMC Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | -33.43% |
| 50-Day Moving Average | 44.85 |
| 200-Day Moving Average | 47.94 |
| Relative Strength Index (RSI) | 40.63 |
| Average Volume (20 Days) | 2,059,559 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BMC Medical had revenue of CNY 1.44 billion and earned 231.65 million in profits. Earnings per share was 1.86.
| Revenue | 1.44B |
| Gross Profit | 770.51M |
| Operating Income | 291.39M |
| Pretax Income | 276.96M |
| Net Income | 231.65M |
| EBITDA | 301.88M |
| EBIT | 291.39M |
| Earnings Per Share (EPS) | 1.86 |
Balance Sheet
The company has 2.90 billion in cash and 554.07 million in debt, with a net cash position of 2.35 billion or 19.04 per share.
| Cash & Cash Equivalents | 2.90B |
| Total Debt | 554.07M |
| Net Cash | 2.35B |
| Net Cash Per Share | 19.04 |
| Equity (Book Value) | 3.13B |
| Book Value Per Share | 25.27 |
| Working Capital | 2.74B |
Cash Flow
In the last 12 months, operating cash flow was 116.02 million and capital expenditures -35.93 million, giving a free cash flow of 80.10 million.
| Operating Cash Flow | 116.02M |
| Capital Expenditures | -35.93M |
| Depreciation & Amortization | 10.49M |
| Net Borrowing | 239.89M |
| Free Cash Flow | 80.10M |
| FCF Per Share | 0.65 |
Margins
Gross margin is 53.56%, with operating and profit margins of 20.26% and 16.10%.
| Gross Margin | 53.56% |
| Operating Margin | 20.26% |
| Pretax Margin | 19.25% |
| Profit Margin | 16.10% |
| EBITDA Margin | 20.99% |
| EBIT Margin | 20.26% |
| FCF Margin | 5.57% |
Dividends & Yields
This stock pays an annual dividend of 0.47, which amounts to a dividend yield of 1.17%.
| Dividend Per Share | 0.47 |
| Dividend Yield | 1.17% |
| Dividend Growth (YoY) | 131.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 26.37% |
| FCF Payout Ratio | 101.67% |
| Buyback Yield | -0.04% |
| Shareholder Yield | 1.13% |
| Earnings Yield | 4.63% |
| FCF Yield | 1.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for BMC Medical is 63.50, which is 57.73% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 63.50 |
| Price Target Difference | 57.73% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 22.93% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on May 28, 2026. It was a forward split with a ratio of 1.4.
| Last Split Date | May 28, 2026 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
BMC Medical has an Altman Z-Score of 7.21 and a Piotroski F-Score of 5.
| Altman Z-Score | 7.21 |
| Piotroski F-Score | 5 |